| An Observational Study of Patients With Dermatologic Disease (NCT07748169) | Target PharmaSolutions, Inc. | 2026-08-01 |
| An Observational Study of Patients With Chronic Kidney Disease (NCT05774392) | Target PharmaSolutions, Inc. | 2025-04-01 |
| An Observational Study of Patients With Autoimmune Disease (NCT05842824) | Target PharmaSolutions, Inc. | 2025-03-31 |
| An Observational Study of Patients Living With Chronic Neurological Diseases (NCT05796037) | Target PharmaSolutions, Inc. | 2025-03-31 |
| An Observational Study of Patients With Chronic Liver Disease (NCT05744713) | Target PharmaSolutions, Inc. | 2024-02-19 |
| An Observational Study of Patients With Chronic Gastrointestinal Disease (NCT05774080) | Target PharmaSolutions, Inc. | 2023-08-01 |
| An Observational Study of Patients With Metabolic Syndrome and Related Conditions (NCT05842811) | Target PharmaSolutions, Inc. | 2023-05-24 |
| An Observational Study of Patients With Coronavirus Disease 2019 (NCT04331886) | Target PharmaSolutions, Inc. | 2020-04-13 |
| A Study of Patients With Chronic Disease (NCT04263727) | Target PharmaSolutions, Inc. | 2020-02-27 |
| A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC (NCT03661866) | Target PharmaSolutions, Inc. | 2018-12-21 |
| An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection (NCT03692897) | Target PharmaSolutions, Inc. | 2018-10-11 |
| Direct Acting Antiviral-Post Authorization Safety Study (NCT03707080) | Target PharmaSolutions, Inc. | 2018-03-09 |